Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-04-09 Purchase |
2025-04-11 9:57 pm |
Keros Therapeutics Inc. | KROS | ADAR1 Capital Management LLC ADAR1 Partners LP ADAR1 Capital Management GP LLC Schneeberger Daniel 10% Owner |
934,258 | $10.13 | $9,464,512 | 5,446,072 (Indirect) |
View |
| 2024-01-04 Sale(A) |
2025-01-24 4:15 pm |
Keros Therapeutics Inc. | KROS | Regnante Keith CHIEF FINANCIAL OFFICER |
40,000 | $45.29 | $1,811,600 | 0 (Direct) |
View |
| 2024-08-13 Sale |
2024-08-15 5:06 pm |
Keros Therapeutics Inc. | KROS | GORDON CARL L Director |
250,000 | $44.01 | $11,002,500 | 119,522 (Indirect) |
View |
| 2024-08-13 Sale |
2024-08-15 5:01 pm |
Keros Therapeutics Inc. | KROS | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director |
250,000 | $44.01 | $11,002,500 | 119,522 (Indirect) |
View |
| 2023-11-04 Sale |
2024-01-08 4:43 pm |
Keros Therapeutics Inc. | KROS | Regnante Keith Chief Financial Officer |
40,000 | $45.29 | $1,811,600 | 53,622 (Direct) |
View |
| 2023-06-08 Sale |
2023-06-12 4:13 pm |
Keros Therapeutics Inc. | KROS | Regnante Keith Chief Financial Officer |
40,000 | $46.61 | $1,864,239 | 207,244 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-04-09 Other |
2025-04-11 9:57 pm |
N/A N/A |
Keros Therapeutics Inc. | KROS | ADAR1 Capital Management LLC ADAR1 Partners LP ADAR1 Capital Management GP LLC Schneeberger Daniel 10% Owner |
899,333 | $0 | 5,446,072 (Indirect) |
View |
Ownership |
2025-04-11 8:58 pm |
N/A N/A |
Keros Therapeutics Inc. | KROS | ADAR1 Capital Management LLC ADAR1 Partners LP ADAR1 Capital Management GP LLC Schneeberger Daniel 10% Owner |
0 | $0 | 5,539,139 (Indirect) |
View |
| 2025-04-04 Exercise |
2025-04-07 4:15 pm |
N/A N/A |
Keros Therapeutics Inc. | KROS | Seehra Jasbir CHIEF EXECUTIVE OFFICER |
49,367 | $0.3 | 554,667 (Direct) |
View |
| 2025-04-04 Exercise |
2025-04-07 4:15 pm |
N/A 2028-03-25 |
Keros Therapeutics Inc. | KROS | Seehra Jasbir CHIEF EXECUTIVE OFFICER |
49,367 | $0 | 554,667 (Direct) |
View |
| 2025-02-18 Option Award |
2025-02-19 4:15 pm |
N/A N/A |
Keros Therapeutics Inc. | KROS | CHYUNG YUNG H. Chief Medical Officer |
44,000 | $0 | 44,000 (Direct) |
View |
| 2025-02-18 Option Award |
2025-02-19 4:15 pm |
N/A N/A |
Keros Therapeutics Inc. | KROS | Regnante Keith CHIEF FINANCIAL OFFICER |
44,000 | $0 | 44,000 (Direct) |
View |
| 2025-02-18 Option Award |
2025-02-19 4:15 pm |
N/A N/A |
Keros Therapeutics Inc. | KROS | Rovaldi Christopher Chief Operating Officer |
60,000 | $0 | 60,000 (Direct) |
View |
| 2024-01-04 Exercise(A) |
2025-01-24 4:15 pm |
N/A N/A |
Keros Therapeutics Inc. | KROS | Regnante Keith CHIEF FINANCIAL OFFICER |
40,000 | $16 | 0 (Direct) |
View |
| 2024-11-08 Option Award |
2024-11-12 4:15 pm |
N/A 2034-11-07 |
Keros Therapeutics Inc. | KROS | CHYUNG YUNG H. Chief Medical Officer |
110,000 | $0 | 110,000 (Direct) |
View |
| 2024-06-03 Option Award |
2024-06-05 4:11 pm |
N/A 2034-06-02 |
Keros Therapeutics Inc. | KROS | BIENAIME JEAN JACQUES Director |
17,600 | $0 | 17,600 (Direct) |
View |
Ownership |
2024-06-05 4:10 pm |
N/A N/A |
Keros Therapeutics Inc. | KROS | BIENAIME JEAN JACQUES Director |
0 | $0 | 200 (Direct) |
View |
| 2024-05-30 Option Award |
2024-06-03 4:15 pm |
N/A 2034-05-29 |
Keros Therapeutics Inc. | KROS | Seth Alpna Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2024-05-30 Option Award |
2024-06-03 4:15 pm |
N/A 2034-05-29 |
Keros Therapeutics Inc. | KROS | Kariv Tomer Director 10% Owner |
10,000 | $0 | 10,000 (Direct) |
View |
| 2024-05-30 Option Award |
2024-06-03 4:15 pm |
N/A 2034-05-29 |
Keros Therapeutics Inc. | KROS | Nussbaum Ran Director 10% Owner |
10,000 | $0 | 10,000 (Direct) |
View |
| 2024-05-30 Option Award |
2024-06-03 4:15 pm |
N/A 2034-05-29 |
Keros Therapeutics Inc. | KROS | Knowles Julius Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2024-05-30 Option Award |
2024-06-03 4:15 pm |
N/A 2034-05-29 |
Keros Therapeutics Inc. | KROS | GRAY MARY ANN Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2024-05-30 Option Award |
2024-06-03 4:15 pm |
N/A 2034-05-29 |
Keros Therapeutics Inc. | KROS | GORDON CARL L Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2024-05-30 Option Award |
2024-06-03 4:15 pm |
N/A 2034-05-29 |
Keros Therapeutics Inc. | KROS | Farzan Nima Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2024-02-23 Option Award |
2024-02-23 5:07 pm |
N/A 2034-02-22 |
Keros Therapeutics Inc. | KROS | Seehra Jasbir CHIEF EXECUTIVE OFFICER |
125,000 | $0 | 125,000 (Direct) |
View |
| 2024-02-13 Option Award |
2024-02-15 8:41 pm |
N/A 2034-02-12 |
Keros Therapeutics Inc. | KROS | Seehra Jasbir CHIEF EXECUTIVE OFFICER |
125,000 | $0 | 125,000 (Direct) |
View |
| 2024-02-13 Option Award |
2024-02-15 8:40 pm |
N/A 2034-02-12 |
Keros Therapeutics Inc. | KROS | Regnante Keith CHIEF FINANCIAL OFFICER |
40,000 | $0 | 40,000 (Direct) |
View |
| 2024-02-13 Option Award |
2024-02-15 8:38 pm |
N/A 2034-02-12 |
Keros Therapeutics Inc. | KROS | Rovaldi Christopher CHIEF OPERATING OFFICER |
150,000 | $0 | 150,000 (Direct) |
View |
| 2024-02-13 Option Award |
2024-02-15 8:37 pm |
N/A 2034-02-12 |
Keros Therapeutics Inc. | KROS | Cooper Simon Peter CHIEF MEDICAL OFFICER |
40,000 | $0 | 40,000 (Direct) |
View |
| 2024-01-04 Exercise |
2024-01-08 4:43 pm |
N/A 2030-04-06 |
Keros Therapeutics Inc. | KROS | Regnante Keith Chief Financial Officer |
40,000 | $0 | 53,622 (Direct) |
View |
| 2023-11-04 Exercise |
2024-01-08 4:43 pm |
N/A N/A |
Keros Therapeutics Inc. | KROS | Regnante Keith Chief Financial Officer |
40,000 | $16 | 53,622 (Direct) |
View |
| 2023-06-08 Exercise |
2023-06-12 4:13 pm |
N/A 2030-04-06 |
Keros Therapeutics Inc. | KROS | Regnante Keith Chief Financial Officer |
40,000 | $0 | 207,244 (Direct) |
View |
| 2023-06-08 Exercise |
2023-06-12 4:13 pm |
N/A N/A |
Keros Therapeutics Inc. | KROS | Regnante Keith Chief Financial Officer |
40,000 | $16 | 207,244 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-08 4:48 pm |
N/A 2033-06-05 |
Keros Therapeutics Inc. | KROS | GORDON CARL L Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-08 4:47 pm |
N/A 2033-06-05 |
Keros Therapeutics Inc. | KROS | Seth Alpna Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-08 4:45 pm |
N/A 2033-06-05 |
Keros Therapeutics Inc. | KROS | Kariv Tomer Director 10% Owner |
10,000 | $0 | 10,000 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-08 4:44 pm |
N/A 2033-06-05 |
Keros Therapeutics Inc. | KROS | Nussbaum Ran Director 10% Owner |
10,000 | $0 | 10,000 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-08 4:42 pm |
N/A 2033-06-05 |
Keros Therapeutics Inc. | KROS | Knowles Julius Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-08 4:41 pm |
N/A 2033-06-05 |
Keros Therapeutics Inc. | KROS | GRAY MARY ANN Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-08 4:38 pm |
N/A 2033-06-05 |
Keros Therapeutics Inc. | KROS | Farzan Nima Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2023-05-01 Option Award |
2023-05-03 4:45 pm |
N/A 2033-04-30 |
Keros Therapeutics Inc. | KROS | Seth Alpna Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2023-04-08 Exercise |
2023-04-11 4:05 pm |
N/A N/A |
Keros Therapeutics Inc. | KROS | Seehra Jasbir Chief Executive Officer |
4,000 | $0.48 | 297,943 (Direct) |
View |
| 2023-04-08 Exercise |
2023-04-11 4:05 pm |
N/A 2029-06-18 |
Keros Therapeutics Inc. | KROS | Seehra Jasbir Chief Executive Officer |
4,000 | $0 | 297,943 (Direct) |
View |
| 2023-02-16 Option Award |
2023-02-17 4:19 pm |
N/A 2033-02-15 |
Keros Therapeutics Inc. | KROS | Rovaldi Christopher Chief Operating Officer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2023-02-16 Option Award |
2023-02-17 4:15 pm |
N/A 2033-02-15 |
Keros Therapeutics Inc. | KROS | Cooper Simon Peter Chief Medical Officer |
40,000 | $0 | 40,000 (Direct) |
View |
| 2023-02-16 Option Award |
2023-02-17 4:14 pm |
N/A 2033-02-15 |
Keros Therapeutics Inc. | KROS | Regnante Keith Chief Financial Officer |
40,000 | $0 | 40,000 (Direct) |
View |